Articles

Drugmaker Investments Will Boost Singapore’s Pharmaceutical Sector, Reflecting Robust Investor Confidence

Pharmaceuticals / Singapore / Thu 23 May, 2024

Key View:

  • Ongoing drugmaker investment will boost Singapore’s status as a key pharmaceutical hub.
  • The government of Singapore will continue to take a proactive role in developing the market’s biomedical manufacturing industry. 
  • Through AstraZeneca’s investment, Singapore's position as an important trading hub for the pharmaceutical sector in the
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.